Hypoxanthine decreases equilibrative type of adenosine transport in lymphocytes from Lesch-Nyhan patients
- PMID: 17883419
- DOI: 10.1111/j.1365-2362.2007.01869.x
Hypoxanthine decreases equilibrative type of adenosine transport in lymphocytes from Lesch-Nyhan patients
Abstract
Background: Lesch-Nyhan (LN) syndrome is associated with deficient hypoxanthine-guanine phosphoribosyltransferase (HPRT) activity, but the connection between the aberrant purine metabolism and the neurological symptoms remains largely unknown. The aim of this study was to determine adenosine transporter subtypes affected by HPRT deficiency and by the associated hypoxanthine excess.
Materials and methods: Nucleoside transporter types (depending on their sodium dependence and 10 microm nitrobenzylthioinosine, NBTI, sensitivity) involved in adenosine transport were compared between peripheral blood lymphocytes (PBL) obtained from nine LN patients, PBL(LN) (2-21 years) and from nine controls, PBL(C) (2-23 years) under basal conditions and after 25 microm hypoxanthine incubation.
Results: We found four types of adenosine transporters in PBL: equilibrative and concentrative transporters that are either sensitive (ENT1 or cs) or insensitive (ENT2 or ci) to NBTI. Adenosine ENT1 uptake was the predominant transporter in both PBL(C) (55%) and PBL(LN) (46%). Under basal conditions no significant differences were found in adenosine transport between PBL(C) and PBL(LN). Incubation of PBL with 25 microm hypoxanthine markedly decreased total adenosine transport in both cell types. Hypoxanthine affected equilibrative transport (mainly ENT2 type) in PBL(LN) and PBL(C). Only in PBL(C) was concentrative transport affected by hypoxanthine. Expressions of human (h) ENT1 and hENT2 mRNA were not significantly modified by hypoxanthine incubation in PBL(C).
Conclusions: This study contributes to further knowledge of the defective adenosine transport found in PBL(LN). Increased hypoxanthine levels, similar to those reported in HPRT deficient patients, reduced adenosine uptake by 32% in PBL(LN) as compared to normal transport.
Similar articles
-
Adenosine transport in HPRT deficient lymphocytes from Lesch-Nyhan disease patients.Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1193-6. doi: 10.1081/NCN-200027463. Nucleosides Nucleotides Nucleic Acids. 2004. PMID: 15571229
-
Hypoxanthine effect on equilibrative and concentrative adenosine transport in human lymphocytes: implications in the phatogenesis of Lesch-Nyhan syndrome.Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):1065-9. doi: 10.1080/15257770600890988. Nucleosides Nucleotides Nucleic Acids. 2006. PMID: 17065065
-
Adenosine transport in peripheral blood lymphocytes from Lesch-Nyhan patients.Biochem J. 2004 Feb 1;377(Pt 3):733-9. doi: 10.1042/BJ20031035. Biochem J. 2004. PMID: 14572307 Free PMC article.
-
[Physiopathology of neurological signs of hypoxanthine-guanine phosphoribosyltransferase deficiency].Rev Neurol. 1998 Dec;27(160):1050-4. Rev Neurol. 1998. PMID: 9951034 Review. Spanish.
-
A review of the implication of hypoxanthine excess in the physiopathology of Lesch-Nyhan disease.Nucleosides Nucleotides Nucleic Acids. 2016 Dec;35(10-12):507-516. doi: 10.1080/15257770.2016.1147579. Nucleosides Nucleotides Nucleic Acids. 2016. PMID: 27906640 Review.
Cited by
-
Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome.Orphanet J Rare Dis. 2007 Dec 8;2:48. doi: 10.1186/1750-1172-2-48. Orphanet J Rare Dis. 2007. PMID: 18067674 Free PMC article. Review.
-
Hypoxanthine deregulates genes involved in early neuronal development. Implications in Lesch-Nyhan disease pathogenesis.J Inherit Metab Dis. 2015 Nov;38(6):1109-18. doi: 10.1007/s10545-015-9854-4. Epub 2015 May 5. J Inherit Metab Dis. 2015. PMID: 25940910
-
Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity.Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6265-70. doi: 10.1073/pnas.1120997109. Epub 2012 Mar 15. Proc Natl Acad Sci U S A. 2012. PMID: 22421436 Free PMC article.
-
Pathophysiological Role of Purines and Pyrimidines in Neurodevelopment: Unveiling New Pharmacological Approaches to Congenital Brain Diseases.Front Pharmacol. 2017 Dec 19;8:941. doi: 10.3389/fphar.2017.00941. eCollection 2017. Front Pharmacol. 2017. PMID: 29375373 Free PMC article. Review.
-
The diagnosis and treatment of disorders of nucleic acid/nucleotide metabolism associated with epilepsy.Acta Epileptol. 2025 Apr 1;7(1):23. doi: 10.1186/s42494-025-00201-x. Acta Epileptol. 2025. PMID: 40217360 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous